API0134抗动脉粥样硬化的实验研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

国家自然科学基金!39470859


An Experimental Study of the Effect of API0134 on Antiatherosclerosis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    为探讨穿心莲成分API0134对动脉粥样硬化性疾病的防治作用,系问高胆固醇喂饲加牛血清白蛋白注射方法建立家克动脉粥样硬化模型的同时,实验组动物加饲API0134,每天150mg/kg,并用硝苯地平作对照,喂养8周.结果发现,API0134用药组血浆高密度脂蛋白胆固醇水平比模型组高,差异有显著性(p<0.05)。模型组主动脉脂质斑块面积百分比为51.2%士20.0%。冠状小动脉粥样硬化发生率为62.4%±174%,冠状动脉管腔狭窄程度为57.6%±17.4%;API0134用药组主动脉脂质斑块面积百分比为7.1%±4,5%,冠状小动脉粥样硬化发生率为12.5%±4.8%;冠状动脉管腔狭窄程度为10.6%±3.4%;两者相比,均有高度显著性差异(p<0.01)。图像分析数据显示.硝苯地平用药组的病变明显重于API0134用药组,但比模型组轻。以上结果表明,API0134具有显著的抗实验性家兔动脉粥样硬化作用,硝苯地平亦有类似作用,但效果不及API0134。

    Abstract:

    Aim observing the anti-atherosclerotic effect of API0134 in vivo.Methods An atheroscletotic rabbit model fed by high cholesterol supplemented with bovine serum albu-min injection was established.Results In model group , the percentage of plaque covering aortic intima (PA ) was 51. 2 % ±20. 0%, the incidence of atherosclernois of small arteries (LA ) and the degree of stenosis of coronarye arteries (DS ) were 62. 4% ± 17. 4 % and 57.6% ±17.4% respectively.In AP10134 treated group, compared with model group. the PA was 7. 1% ± 4. 5 %, LA was 12. 5% ± 4. 8%, DS was 10. 6% ±3.4%. While in nifedipine treated group, the image analvsis gave a significantly bigher values than APIC134 treated group, but lower then those of model group.Conclusion API0134 exeits strong anti-atheroscle- rotic effect in experimental rabbit. Althouth nifedip-ine has the similar effeet but with a slightly weaker ac-tion.

    参考文献
    相似文献
    引证文献
引用本文

王宏伟,赵华月,熊一力. API0134抗动脉粥样硬化的实验研究[J].中国动脉硬化杂志,1997,5(1):37~40.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:1996-12-10
  • 最后修改日期:1997-02-26
  • 录用日期:
  • 在线发布日期: